Cargando…
Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
Atypical cannabinoid compounds O-1602 and O-1918 are ligands for the putative cannabinoid receptors G protein-coupled receptor 55 and G protein-coupled receptor 18. The role of O-1602 and O-1918 in attenuating obesity and obesity-related pathologies is unknown. Therefore, we aimed to determine the r...
Autores principales: | Simcocks, Anna C, Jenkin, Kayte A, O’Keefe, Lannie, Samuel, Chrishan S, Mathai, Michael L, McAinch, Andrew J, Hryciw, Deanne H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391900/ https://www.ncbi.nlm.nih.gov/pubmed/30707678 http://dx.doi.org/10.1530/EC-18-0535 |
Ejemplares similares
-
The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity
por: Simcocks, Anna C., et al.
Publicado: (2020) -
CB(1) Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity
por: O’Keefe, Lannie, et al.
Publicado: (2022) -
Treatment of Diet-Induced Obese Rats with CB(2) Agonist AM1241 or CB(2) Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue
por: O’Keefe, Lannie, et al.
Publicado: (2023) -
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism
por: Naughton, Shaan S., et al.
Publicado: (2013) -
Editorial: Peripheral Regulators of Obesity
por: McAinch, Andrew J., et al.
Publicado: (2019)